Q0247
HCPCSSotrovimab
Verified from hospital fileNot a bill estimate
iDirect answer
Based on the latest published hospital price files, code Q0247 (Sotrovimab) appears at 6 hospitals with disclosed cash prices from $0.01 to $0.01. This is public hospital price transparency data, not a guaranteed estimate of your bill.
Published-price availability
5
hospitals publish a price
1
list this service without a published price
4
Cash
4
List
1
Negotiated
0
Allowed
A blank price (“—”) means a hospital names this service but did not publish a dollar amount — it is not a free service or a $0 price.
Compare Q0247 prices
Filter by hospital, city, setting, or payer — the summary and charts update with your filters.
4
Hospitals
6
Prices shown
$0.01
Lowest cash
$0.01
Highest cash
code Q0247 cash price4 disclosed · 4 hospitals
$0.01median ~$0.01$0.01
Lowest cash price by hospital
- Mount Sinai Brooklyn$0.01
- Mount Sinai Hospital$0.01
- Mount Sinai Queens$0.01
Cash price by city
Reflects your current filters.
Cash price by city$0.01 – $0.01
- Brooklyn · 1 hospital$0.01
- New York · 2 hospitals$0.01
- Long Island · 1 hospital$0.01
6 prices shown.
| Service | Hospital | Code | List price | Cash price | Negotiated range | Allowed (median) | |
|---|---|---|---|---|---|---|---|
| Sotrovimab Outpatient | Endeavor Health Edward Hospital | Q0247 HCPCS | — | — | $5,267 – $5,267 | — | |
| Sotrovimab Outpatient | University of Chicago Medical Center | Q0247 HCPCS | — | — | — | — | |
| sotrovimab 500 mg/8 mL (62.5 mg/mL) solution 8 mL Vial Inpatient & outpatient | Mount Sinai Brooklyn | Q0247 HCPCS | $0.01 | $0.01 | — | — | |
| sotrovimab 500 mg/8 mL (62.5 mg/mL) solution 8 mL Vial Inpatient & outpatient | Mount Sinai Hospital | Q0247 HCPCS | $0.01 | $0.01 | — | — | |
| sotrovimab 500 mg/8 mL (62.5 mg/mL) solution 8 mL Vial Inpatient & outpatient | Mount Sinai Queens | Q0247 HCPCS | $0.01 | $0.01 | — | — | |
| sotrovimab 500 mg/8 mL (62.5 mg/mL) solution 8 mL Vial Inpatient & outpatient | Mount Sinai Morningside | Q0247 HCPCS | $0.01 | $0.01 | — | — |
How to read these prices
- Cash price
- The discounted self-pay price for paying directly, without insurance.
- List price
- The hospital’s full undiscounted charge — rarely what anyone pays.
- Negotiated rate
- A rate for a specific insurer and plan; your share depends on your benefits.
- Allowed amount
- A historical reference for what was actually allowed, where disclosed.
Hospitals that publish Q0247 prices
Open a hospital to see this code in the context of its full published prices.
Code Q0247: frequently asked
- What does code Q0247 cost?
- Across the published hospital price files, the disclosed cash price for Q0247 ranges from $0.01 to $0.01. This is public hospital price transparency data, not a guaranteed estimate of your bill.
- Will this be my final bill?
- Actual patient responsibility may vary based on your insurance plan, deductible, coinsurance, network status, diagnosis, setting, bundled services, clinical circumstances, and hospital billing practices.
- What is code Q0247?
- Q0247 is the billing code hospitals use to identify "Sotrovimab" on their published price files. We use it to line up the same service across different hospitals.
- Why do prices for this code differ between hospitals?
- Each hospital sets its own prices and negotiates separately with each insurer, so the disclosed price for the same code can vary widely from one hospital to another — and even between plans at a single hospital. Comparing the published figures is what this page is for; a difference does not by itself mean one hospital is better or worse.
- What this page is not
- It is not a quote, a guarantee, or medical advice. It shows what hospitals have published for this code, so you can compare and ask informed questions — your actual cost depends on your insurance, the exact services performed, and the care setting.